Breast cancer patients with oestrogen-receptor (ER) negative tumours usually fail to respond to endocrine therapy as opposed to patients with ER positive tumours who have a response rate of 50-60% (Young et al., 1980; DeSombre et al., 1979) , and response is more readily elicited in those tumours that have a high ER concentration (Maas et al., 1980) . Furthermore, it is recognized that the ER content is vested with prognostic significance in predicting the disease-free interval and survival (Allegra et al., 1979; Kinne et al., 1981) . Recently, it has been suggested, however, that the greater overall survival of receptor-positive patients is mainly due to an increase in survival following relapse, and the same study failed to confirm the predictive value of ER regarding disease-free interval (Howat et al., 1985) .
The proven clinical value of biochemical ER assays notwithstanding, their application is hampered by several factors such as cost, the difficulties encountered in performing the assay and the inability of such assays to reveal tumour heterogeneity. Several immunocytochemical staining methods have consequently been developed allowing direct morphological demonstration of ER. In these methods, resort is made either to antibodies against oestrogen, labelled oestrogen binding to ER (Parl, 1984) , polyclonal antireceptor antibodies (Tamura et al., 1984) , or recently to monoclonal antibodies raised against oestrogen receptor protein (Greene et al., 1980; Greene et al., 1982) . antibodies has not yet been established, and interest is increasingly directed towards the use of monoclonal antibodies.
The oestrogen-receptor immunocytochemical assay (ER-ICA) developed by King and Greene (Greene & Jensen, 1982; King et al., 1985) yields reproducible results and good correlation with conventional ER assays (King et al., 1985; Thorpe et al., 1985) , and in one report it was even better at predicting the response to hormonal treatment (Pertschuk et al., 1985) . So far, the ER-ICA assay has only been used on frozen tissue specimens, and application on conventional, neutral formalin-fixed specimens has failed, apparently because of loss of antigenic ER expression (King et al., 1985; Pertschuk et al., 1985) . Poulsen et al. (1985) obtained reproducible results in paraffin-embedded tissue, but their specimens were fixed in the acidic Bouin's solution. Shimada et al. (1985) obtained similar results in formalin-fixed paraffin sections, but it was necessary to use cold formalin, which differs from the conventional method of fixation used in most clinical laboratories.
The aim of this study was to develop an immunohistochemical assay for semiquantitative detection of ER in conventional formalin-fixed, paraffin-embedded histological specimens.
A sample of ER positive tumour blocks was selected, cut, and conventionally deparaffinized. Staining was attempted, using the ER-ICA as described by King et al. (1985) , but no nuclear or cytoplasmic staining was observed. The incubation period with the monoclonal antibody was then increased from 30 min to 16 h at 4°C, but the results were still negative even when resorting to another selection of tumours. Staining was then attempted using a variety of amplification techniques different from the original peroxidase/ antiperoxidase technique. A first attempt involving incubation with rabbit anti-rat IgG followed by peroxidase-conjugated swine anti-rabbit IgG proved unsuccessful. Secondly, amplification with an avidin-biotin system was attempted, primarily using 692 J. ANDERSEN et al. biotin-conjugated rabbit anti-rat IgG and avidin plus biotinylated peroxidase. A distinct though faint nuclear staining was observed. Finally, we used biotin-conjugated foat anti-rat IgG and avidin plus biotinylated peroxidase which gave a moderate to strong nuclear staining of tumour cells. The sophistication of this method was tested by checkerboard studies (variation in concentration of binding antibody, trypsination) (summarized in Table I) , and the best, reproducible results were obtained by the technique described below. Primary breast cancer specimens from 35 women were studied. The tissue blocks, stored 1-5 years at room temperature, were fixed according to routine laboratory procedures in phosphate-buffered 4% formaldehyde, embedded in paraffin. Assessment of the ER content by conventional dextran-coatedcharcoal (DCC) assay at the time of mastectomy showed a widely different oestrogen receptor content. The DCC assay was performed at the Receptor Laboratory, the Institute of Cancer Research, Aarhus, Denmark. The method, which has previously been described by Poulsen (1982) , is in accordance with the EORTC standard (EORTC Breast Cancer Cooperative Group, 1980) . Tissue blocks were cut in 6 gm sections, conventionally deparaffinized, and rehydrated. The specimens were washed in Tris-PBS (0.5 M Tris-HCI in PBS (NaCl, 8.5 g: KH2PO4, 0.25 g: K2HPO4x3H2O, 1.43g in 1,000 ml H20), pH 7.2) and trypsinised with 0.1% trypsin in 0.1% CaCl2 for 15 min, followed by washing in Tris-PBS for 3 x 5 min. The sections were incubated with normal goat serum diluted 1:10 for 20 min to block nonspecific staining and without washing covered with primary monoclonal antibody (H 222, 0.1 ig ml -1, obtained from the Abbott ER-ICA kit, Abbott Laboratories, North Chicago, Ill., USA), and incubated at 4°C for 16h. After washing in Tris-PBS, the sections were covered with biotinconjugated goat anti-rat IgG 0.5mgml-1, diluted 1:10 (Sigma Chemical Co., St. Louis, MO, USA) for 60min, washed, and incubated with Vectastain avidin-biotin complex for 60min according to the manufacturer's prescription (Vector Laboratories, Burlinggame, CA, USA), then washed and stained with 0.04% 3-amino-9-ethylcarbazole with 0.01% H202 (Sigma Chemical Co.) for 11 min in the dark. The sections were washed, counterstained with haematoxylin, washed, and mounted in gelatin.
To every specimen belonged a negative control established by replacement of the monoclonal antibody with normal rat IgG, 0.1 mgml 1 (Abbott Laboratories) to check endogenous peroxidase activity and non-specific binding of the binding antibody. Positive controls consisted of biochemically confirmed ER-rich breast tumours.
Positive staining was localized to the nucleus of malignant epithelial cells (Figure 1 ) in accordance with the results obtained by others (King et al., 1985; Pertshuk et al., 1985; Poulsen et al., 1985; Thorpe et al., 1985) . Variations in staining intensity were observed between tumour cells and between different areas within the same section, a phenomenon that might be attributed to the heterogeneity of the tumour cell population as proposed by Poulsen (Poulsen et al., 1981) . In one case a faint cytoplasmic staining was seen in single tumour cells. No controls showed signs of staining. As expected, positive staining was seen in cells with endogenous peroxidase activity, i.e. erythrocytes and inflammatory cells.
The staining intensity was graded 0-1-2-3, with 3 representing the most pronounced staining. The proportion of positive cells was evaluated and graded 0-1-2-3 (1: <10% positive cells; 2: 10-50% positive cells; 3: >50% positive cells). The two values obtained were multiplied to give a 0-9 semiquantitative score of oestrogen receptor content.
The specimens were evaluated independently by J.A. and H.S.P. without knowledge of the biochemically determined ER content. Interobserver agreement was obtained both qualitatively and quantitatively in 30 of the 35 cases. Disagreement in the other 5 cases was primarily focussed on the degree of staining intensity.
Tumours with an ER content .10 fmol mg1 cytosol protein were considered positive by the biochemical assay, whereas specimens showing nuclear staining were considered positive by the histochemical assay. The quantitative relationship between the semiquantitative ER assay and the conventional DCC ER assay is shown in Figure 2 . Statistical analyses showed the two assays to be very well correlated (r: 0.91, P<<0.001, regression analysis, Student's t test). As shown in Table II , the degree of nuclear staining and the proportion of positive cells seem to be equally well correlated with the DCC assay as compared to the total score. It is important to note that there were no false positives in the histochemical assay if the DCC assay were used as the reference. In conclusion, the results in this study on conventionally formalin-fixed, paraffin-embedded breast cancer tissue seem comparable to those achieved by assays using frozen tissue sections, and are highly correlated with those obtained by the conventional biochemical DCC assay. This immunohistochemical method opens up a range of possibilities such as the use of the wealth of samples stored in pathological departments for retrospective studies, determination of the ER content in tumours on which DCC assay was not performed, correlation of the ER content with histopathological features, and ER analysis on very small tissue samples. Finally, the observation in this study of the lack of nuclear staining in tumours biochemically classified as ER positive could correspond to the findings of Leake et al. (1981) , who found that tumours containing ER only in the cytosol have lower response rates to hormonal manipulation as compared to tumours containing ER both in the cytosol and nuclear extract. Ongoing clinical studies directly correlating immunohistochemical ER scores with response will hopefully elucidate this issue.
